Overview

Study to Evaluate the Influence of Hydrochlorothiazide on Dermal Photosensitivity and DNA Stability - a Pilot Study (HCTox Study)

Status:
Recruiting

Trial end date:
2021-06-30

Target enrollment:

Participant gender:

Summary

The clinical trial is designed as a national, prospective, single-center, double-blind, parallel group, randomized, controlled, interventional trial to investigate whether a therapy with HCT compared with placebo can affect dermal photosensitivity and DNA stability.

Phase:

Phase 1

Details

Lead Sponsor:

Saarland University
Universität des Saarlandes

Treatments:

Hydrochlorothiazide